• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌 F-FDG PET 影像组学中示踪剂摄取时间的影响。

Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer F-FDG PET Radiomics.

机构信息

Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands;

Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

出版信息

J Nucl Med. 2022 Jun;63(6):919-924. doi: 10.2967/jnumed.121.262660. Epub 2021 Dec 21.

DOI:10.2967/jnumed.121.262660
PMID:34933890
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9157719/
Abstract

PET radiomics applied to oncology allow the measurement of intratumoral heterogeneity. This quantification can be affected by image protocols; hence, there is an increased interest in understanding how radiomic expression on PET images is affected by different imaging conditions. To address that interest, this study explored how radiomic features are affected by changes in F-FDG uptake time, image reconstruction, lesion delineation, and radiomic binning settings. Ten non-small cell lung cancer patients underwent F-FDG PET on 2 consecutive days. On each day, scans were obtained at 60 and 90 min after injection and reconstructed following EARL version 1 and with point-spread-function resolution modeling (PSF-EARL2). Lesions were delineated with an SUV threshold of 4.0, with 40% of SUV, and with a contrast-based isocontour. PET image intensity was discretized with both a fixed bin width (FBW) and a fixed bin number before the calculation of the radiomic features. Repeatability of features was measured with the intraclass correlation coefficient, and the change in feature value over time was calculated as a function of its repeatability. Features were then classified into use-case scenarios based on their repeatability and susceptibility to tracer uptake time. With PSF-EARL2 reconstruction, 40% of SUV lesion delineation, and FBW intensity discretization, most features (94%) were repeatable at both uptake times (intraclass correlation coefficient > 0.9), 35% being classified for dual-time-point use cases as being sensitive to changes in uptake time, 39% were classified for cross-sectional studies with an unclear dependency on time, 20% were classified for cross-sectional use while being robust to uptake time changes, and 6% were discarded for poor repeatability. EARL version 1 images had 1 fewer repeatable feature (neighborhood gray-level different matrix coarseness) than PSF-EARL2; the contrast-based delineation had the poorest repeatability of the delineation methods, with 45% of features being discarded; and fixed bin number resulted in lower repeatability than FBW (45% and 6% of features were discarded, respectively). Repeatability was maximized with PSF-EARL2 reconstruction, lesion delineation at 40% of SUV, and FBW intensity discretization. On the basis of their susceptibility to uptake time, radiomic features were classified into specific non-small cell lung cancer PET radiomics use cases.

摘要

PET 放射组学在肿瘤学中的应用可以测量肿瘤内异质性。这种定量可能会受到图像协议的影响;因此,人们越来越感兴趣于了解 PET 图像上的放射组学表达如何受到不同成像条件的影响。为了解决这一兴趣,本研究探讨了放射性特征如何受到 F-FDG 摄取时间、图像重建、病变勾画和放射组学分箱设置变化的影响。 10 名非小细胞肺癌患者在连续两天进行 F-FDG PET 检查。在每一天,分别在注射后 60 分钟和 90 分钟获得扫描,并按照 EARL 版本 1 和点扩散函数分辨率建模 (PSF-EARL2) 进行重建。病变采用 SUV 阈值为 4.0、SUV 的 40%和基于对比的等浓度曲线进行勾画。在计算放射组学特征之前,通过固定的 bin 宽度 (FBW) 和固定的 bin 数量对 PET 图像强度进行离散化。使用组内相关系数测量特征的重复性,根据其重复性计算特征值随时间的变化。然后根据其重复性和对示踪剂摄取时间的敏感性,将特征分类到用例场景中。 使用 PSF-EARL2 重建、40%的 SUV 病变勾画和 FBW 强度离散化,在两种摄取时间下,大多数特征(94%)均具有可重复性(组内相关系数>0.9),35%被归类为双时间点用例,对摄取时间变化敏感,39%被归类为横断面研究,与时间无明显依赖性,20%被归类为横断面用例,对摄取时间变化具有鲁棒性,6%因重复性差而被丢弃。与 PSF-EARL2 相比,EARL 版本 1 图像的可重复性特征少 1 个(邻域灰度差矩阵粗糙度);基于对比的勾画方法的重复性最差,45%的特征被丢弃;与 FBW 相比,固定 bin 数导致的重复性更低(分别有 45%和 6%的特征被丢弃)。 使用 PSF-EARL2 重建、40%的 SUV 病变勾画和 FBW 强度离散化可最大程度地提高重复性。基于对摄取时间的敏感性,将放射组学特征分类为特定的非小细胞肺癌 PET 放射组学用例。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/16b91fb4bc29/jnumed.121.262660f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/3a50510f7781/jnumed.121.262660absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/5c6b91a7174e/jnumed.121.262660f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/0b4f05a7dc81/jnumed.121.262660f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/afe9ff25d2f0/jnumed.121.262660f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/16b91fb4bc29/jnumed.121.262660f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/3a50510f7781/jnumed.121.262660absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/5c6b91a7174e/jnumed.121.262660f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/0b4f05a7dc81/jnumed.121.262660f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/afe9ff25d2f0/jnumed.121.262660f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5066/9157719/16b91fb4bc29/jnumed.121.262660f4.jpg

相似文献

1
Effects of Tracer Uptake Time in Non-Small Cell Lung Cancer F-FDG PET Radiomics.非小细胞肺癌 F-FDG PET 影像组学中示踪剂摄取时间的影响。
J Nucl Med. 2022 Jun;63(6):919-924. doi: 10.2967/jnumed.121.262660. Epub 2021 Dec 21.
2
Repeatability of F-FDG PET radiomic features: A phantom study to explore sensitivity to image reconstruction settings, noise, and delineation method.重复 F-FDG PET 放射组学特征:一项旨在探索对图像重建设置、噪声和勾画方法的敏感性的体模研究。
Med Phys. 2019 Feb;46(2):665-678. doi: 10.1002/mp.13322. Epub 2018 Dec 28.
3
Repeatability of Radiomic Features in Non-Small-Cell Lung Cancer [(18)F]FDG-PET/CT Studies: Impact of Reconstruction and Delineation.非小细胞肺癌[(18)F]FDG-PET/CT研究中影像组学特征的可重复性:重建与勾画的影响
Mol Imaging Biol. 2016 Oct;18(5):788-95. doi: 10.1007/s11307-016-0940-2.
4
Repeatability of F-FDG PET Radiomic Features in Cervical Cancer.宫颈癌 F-FDG PET 影像组学特征的可重复性。
J Nucl Med. 2021 May 10;62(5):707-715. doi: 10.2967/jnumed.120.247999. Epub 2020 Oct 2.
5
Experimental Multicenter and Multivendor Evaluation of the Performance of PET Radiomic Features Using 3-Dimensionally Printed Phantom Inserts.使用三维打印的 phantom 插件进行 PET 放射组学特征的多中心、多供应商性能的实验评估。
J Nucl Med. 2020 Mar;61(3):469-476. doi: 10.2967/jnumed.119.229724. Epub 2019 Aug 16.
6
Robustness of Radiomic Features in [C]Choline and [F]FDG PET/CT Imaging of Nasopharyngeal Carcinoma: Impact of Segmentation and Discretization.鼻咽癌[C]胆碱和[F]氟代脱氧葡萄糖PET/CT成像中影像组学特征的稳健性:分割和离散化的影响
Mol Imaging Biol. 2016 Dec;18(6):935-945. doi: 10.1007/s11307-016-0973-6.
7
Robustness of [F]FDG PET/CT radiomic analysis in the setting of drug-induced cardiotoxicity.药物性心脏毒性中 [F]FDG PET/CT 影像组学分析的稳健性。
Comput Methods Programs Biomed. 2024 Feb;244:107981. doi: 10.1016/j.cmpb.2023.107981. Epub 2023 Dec 15.
8
Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.基于[18F]-FDG 的 PET/CT 与 PET/MR 影像中影像组学特征的可互换性。
Med Phys. 2019 Apr;46(4):1677-1685. doi: 10.1002/mp.13422. Epub 2019 Feb 22.
9
Repeatability of Quantitative Whole-Body 18F-FDG PET/CT Uptake Measures as Function of Uptake Interval and Lesion Selection in Non-Small Cell Lung Cancer Patients.非小细胞肺癌患者全身18F-FDG PET/CT定量摄取测量的可重复性与摄取间隔及病变选择的关系
J Nucl Med. 2016 Sep;57(9):1343-9. doi: 10.2967/jnumed.115.170225. Epub 2016 Apr 21.
10
Repeatability of [F]FDG PET/CT total metabolic active tumour volume and total tumour burden in NSCLC patients.非小细胞肺癌患者中[F]FDG PET/CT总代谢活性肿瘤体积和总肿瘤负荷的重复性
EJNMMI Res. 2019 Feb 7;9(1):14. doi: 10.1186/s13550-019-0481-1.

引用本文的文献

1
Development and validation of an F-FDG PET/CT radiomic nomogram for predicting axillary lymph-node status after neoadjuvant chemotherapy for breast cancer: a multicenter study.用于预测乳腺癌新辅助化疗后腋窝淋巴结状态的F-FDG PET/CT影像组学列线图的开发与验证:一项多中心研究
Ann Nucl Med. 2025 Aug 17. doi: 10.1007/s12149-025-02099-4.
2
Elucidation of FDG-PET Imaging Characteristics that Reflect the Heterogeneity within Tumors Due to Variability in Metabolic Activity: A Phantom Study.阐明反映因代谢活性变化导致肿瘤内部异质性的FDG-PET成像特征:一项体模研究。
World J Nucl Med. 2024 Nov 19;24(2):97-106. doi: 10.1055/s-0044-1795105. eCollection 2025 Jun.
3

本文引用的文献

1
Adding the temporal domain to PET radiomic features.在 PET 放射组学特征中添加时间域。
PLoS One. 2020 Sep 23;15(9):e0239438. doi: 10.1371/journal.pone.0239438. eCollection 2020.
2
Harmonization strategies for multicenter radiomics investigations.多中心放射组学研究的协调策略。
Phys Med Biol. 2020 Dec 17;65(24):24TR02. doi: 10.1088/1361-6560/aba798.
3
Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies.改良后的 ComBat 用于多中心研究中放射组学特征的调和性能比较。
Mitigating the impact of image processing variations on tumour [F]-FDG-PET radiomic feature robustness.
减轻图像处理变化对肿瘤 [F]-FDG-PET 放射组学特征稳健性的影响。
Sci Rep. 2024 Jul 15;14(1):16294. doi: 10.1038/s41598-024-67239-8.
4
Semi-automated segmentation methods of SSTR PET for dosimetry prediction in refractory meningioma patients treated by SSTR-targeted peptide receptor radionuclide therapy.采用 SSTR 靶向肽受体放射性核素治疗难治性脑膜瘤患者的 SSTR PET 半自动分割方法进行剂量预测。
Eur Radiol. 2023 Oct;33(10):7089-7098. doi: 10.1007/s00330-023-09697-8. Epub 2023 May 6.
5
The role of radiomics with machine learning in the prediction of muscle-invasive bladder cancer: A mini review.基于机器学习的影像组学在肌层浸润性膀胱癌预测中的作用:一篇综述。
Front Oncol. 2022 Aug 17;12:990176. doi: 10.3389/fonc.2022.990176. eCollection 2022.
6
Monitoring of Current Cancer Therapy by Positron Emission Tomography and Possible Role of Radiomics Assessment.正电子发射断层扫描监测当前癌症治疗及放射组学评估的可能作用。
Int J Mol Sci. 2022 Aug 20;23(16):9394. doi: 10.3390/ijms23169394.
7
Preclinical and first-in-human evaluation of F-labeled D-peptide antagonist for PD-L1 status imaging with PET.用于 PD-L1 状态 PET 成像的 F 标记 D-肽拮抗剂的临床前和人体首次评估。
Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4312-4324. doi: 10.1007/s00259-022-05876-9. Epub 2022 Jul 14.
Sci Rep. 2020 Jun 24;10(1):10248. doi: 10.1038/s41598-020-66110-w.
4
The Image Biomarker Standardization Initiative: Standardized Quantitative Radiomics for High-Throughput Image-based Phenotyping.影像生物标志物标准化倡议:高通量基于影像表型的标准化定量放射组学。
Radiology. 2020 May;295(2):328-338. doi: 10.1148/radiol.2020191145. Epub 2020 Mar 10.
5
Robust, independent and relevant prognostic 18F-fluorodeoxyglucose positron emission tomography radiomics features in non-small cell lung cancer: Are there any?非小细胞肺癌中稳健、独立且相关的 18F-氟脱氧葡萄糖正电子发射断层扫描放射组学特征:存在吗?
PLoS One. 2020 Feb 25;15(2):e0228793. doi: 10.1371/journal.pone.0228793. eCollection 2020.
6
Quantitative implications of the updated EARL 2019 PET-CT performance standards.2019年EARL更新的PET-CT性能标准的定量影响。
EJNMMI Phys. 2019 Dec 26;6(1):28. doi: 10.1186/s40658-019-0257-8.
7
The clinical value of texture analysis of dual-time-point F-FDG-PET/CT imaging to differentiate between F-FDG-avid benign and malignant pulmonary lesions.双时相 F-FDG-PET/CT 纹理分析在鉴别 F-FDG 摄取的肺良恶性病变中的临床价值。
Eur Radiol. 2020 Mar;30(3):1759-1769. doi: 10.1007/s00330-019-06463-7. Epub 2019 Nov 14.
8
The Dark Side of Radiomics: On the Paramount Importance of Publishing Negative Results.放射组学的阴暗面:论发表阴性结果的至关重要性。
J Nucl Med. 2019 Nov;60(11):1543-1544. doi: 10.2967/jnumed.119.235325. Epub 2019 Sep 20.
9
Bone Marrow and Tumor Radiomics at F-FDG PET/CT: Impact on Outcome Prediction in Non-Small Cell Lung Cancer.骨髓和肿瘤 CT 体层摄影术 F-FDG 摄取的放射组学:对非小细胞肺癌预后预测的影响。
Radiology. 2019 Nov;293(2):451-459. doi: 10.1148/radiol.2019190357. Epub 2019 Sep 17.
10
Multicentric validation of radiomics findings: challenges and opportunities.放射组学研究结果的多中心验证:挑战与机遇
EBioMedicine. 2019 Sep;47:20-21. doi: 10.1016/j.ebiom.2019.08.054. Epub 2019 Aug 29.